{"ticker": {"uuid": "24ac7ce2-6e5a-4d90-91cd-bfc6dec1083a", "symbol": "LNSR", "name": "LENSAR Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price-Driven Insight from (LNSR) for Rule-Based Strategy", "summary": "This article provides a price-driven analysis for Lensar Inc. (LNSR), highlighting near-term weak sentiment and potential long-term weakness resumption. It outlines specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, with de", "url": "https://news.stocktradersdaily.com/news_release/1/Price-Driven_Insight_from_LNSR_for_Rule-Based_Strategy_071326060001_1783936801.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-13T07:43:17", "published_display": "13 Jul 2026 07:43", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "This article displays the \"Price to earnings forward\" metric for LENSAR, Inc. (NASDAQ:LNSR) on TradingView. It presents financial information for the company, accessible through various features on the platform. The content is primarily a data point presented within the TradingVi", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T18:11:11", "published_display": "05 Jul 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "The article provides a financial snapshot for LENSAR, Inc. (NASDAQ:LNSR), specifically focusing on its \"Price to book forward\" metric. It appears to be an excerpt from a financial data platform like TradingView, indicating that the market for LNSR is currently closed with no trad", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T05:40:37", "published_display": "02 Jul 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LNSR) Price Dynamics and Execution-Aware Positioning", "summary": "This article analyzes Lensar Inc. (NASDAQ: LNSR) with a focus on its price dynamics and execution-aware positioning. It highlights weak near-term sentiment impacting the stock and identifies resistance levels, suggesting a potential short setup with significant downside. The repo", "url": "https://news.stocktradersdaily.com/news_release/149/LNSR_Price_Dynamics_and_Execution-Aware_Positioning_070226045202_1782982322.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-02T05:11:29", "published_display": "02 Jul 2026 05:11", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "This article displays financial information for LENSAR, Inc. (NASDAQ: LNSR), specifically its forward price-to-sales ratio. It indicates the market status as closed with no trades and highlights that the content is provided by TradingView, with market data from ICE Data Services ", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T00:40:05", "published_display": "02 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "This article focuses on the enterprise value to revenue forward metric for LENSAR, Inc. (NASDAQ: LNSR) on TradingView. It appears to be an unpopulated financial data page, showing the structure for displaying such information rather than actual figures. The content primarily cons", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T07:14:55", "published_display": "01 Jul 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) added to Russell Microcap Value Benchmark Index", "summary": "LENSAR, Inc. (NasdaqCM: LNSR) has been added to the Russell Microcap Value Benchmark Index, as announced on June 29, 2026. This inclusion comes despite several recent exclusions from other Russell indexes, highlighting a reclassification within the Russell family of benchmarks. T", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-added-to-russell-microcap-value-benchmark-index-ce7f5fdfd988f624", "source_name": "www.marketscreener.com", "published_at": "2026-06-30T02:40:05", "published_display": "30 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 2000 Dynamic Index", "summary": "LENSAR, Inc. (NasdaqCM:LNSR) has been dropped from several Russell indices, including the Russell 2000 Dynamic Index, Russell 3000E Index, Russell Small Cap Completeness Index, Russell 2500 Index, Russell 3000 Index, Russell 2000 Index, Russell 3000E Growth Benchmark, and Russell", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-dropped-from-russell-2000-dynamic-index-ce7f5fdfdc8df121", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:41:35", "published_display": "29 Jun 2026 21:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 3000E Index", "summary": "LENSAR, Inc. (NasdaqCM:LNSR), a commercial-stage medical device company specializing in cataract treatment systems, has been removed from the Russell 3000E Index. The company's stock currently trades at $5.830 with a recent -0.17% change. This news follows several other index reb", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-dropped-from-russell-3000e-index-ce7f5fdfda88f527", "source_name": "marketscreener.com", "published_at": "2026-06-29T13:59:00", "published_display": "29 Jun 2026 13:59", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 2500 Index", "summary": "LENSAR, Inc. (NasdaqCM: LNSR), a medical device company specializing in advanced cataract treatment systems, has been dropped from the Russell 2500 Index. This update was reported on June 29, 2026, coinciding with several other Russell index changes for the company. LENSAR's prod", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-dropped-from-russell-2500-index-ce7f5fdfd98cf025", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T10:17:00", "published_display": "29 Jun 2026 10:17", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell Small Cap Comp Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPVDFkVTNGeE05RXo4eXRxTEtlWUxUNGE5M0NMNUJWM0NVdkhSNk1BTmhrTFd4RnNaejdfYnRwOXdXMUJXZ2FVZ1JUMnBhNGZ5YkRsZ3UwaFJhU25TaU1oLVN0M09BR01IUUNGcmcxM1I1aWQzY3V4bHE3b1kwX0U5cDZveUt1aXV6RkdRdWl4UnIxc1dCU0R3ZzVmVVI4UnZ5QjVuYmRSYTdVanB4WDhZWFRoNlUtWGFJZElGcVliYmhWRnlOM1dISnZR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPaFFoMEVSN1JhWUNsVXptRV9NTFBJNDhZYnJJZnl4cndjdzhUaXZOZ2kxMExTLVJGejNwS2hsRDUtcDRDM29PenItcjhuRVFsNDRlWVhYSmVfQmdjVlV0OFd6QjB1QWdmNVdQT1NRMDFBazRyRzZtMk9KSGI0Y05jRkxNdGd3a0hKZERRS2NtNzhyem9Da2ZiOXRWbVRfRWxpZTVSWFgwT1prTEd5WTUtQndOWkRoNTg?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc Actuals & Estimates (NASDAQ:LNSR)", "summary": "This article provides an overview of LENSAR, Inc.'s (NASDAQ: LNSR) financial actuals and estimates, along with analyst insights and key stock information. It covers current stock price, historical highs and lows, volatility, market capitalization, upcoming earnings reports, reven", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T05:11:13", "published_display": "26 Jun 2026 05:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNSR Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for LENSAR, Inc. (LNSR) stock, detailing analyst opinions, historical price performance, and key financial metrics. It includes frequently asked questions about the company's stock, market capitalization, earnings, and volatility,", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:10:22", "published_display": "26 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Valuation: PE, PB & Fair Value Analysis", "summary": "LENSAR Inc (LNSR) currently holds a valuation score of 9.27, placing it 26th out of 204 companies in the Healthcare Equipment & Supplies industry. Its P/E ratio stands at 2.34, which is 9.44% below its recent high and significantly above its recent low. However, relevant data for", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T23:39:47", "published_display": "23 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[ARS] LENSAR, Inc. SEC Filing", "summary": "This article announces an SEC filing of Form ARS by LENSAR, Inc. (LNSR) on June 23, 2026, accessible as a PDF document. The filing has a low impact and neutral sentiment according to StockTitan's Rhea-AI. The article also provides recent news and other SEC filings related to LENS", "url": "https://www.stocktitan.net/sec-filings/LNSR/ars-lensar-inc-sec-filing-e0c909ca4897.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:45", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (NASDAQ: LNSR) schedules 2026 virtual meeting, say-on-pay and auditor vote", "summary": "LENSAR (NASDAQ: LNSR) has scheduled its 2026 virtual annual shareholder meeting for August 4, 2026, at 11:00 a.m. Eastern Time. Shareholders will vote on the election of three Class III directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor for 2026,", "url": "https://www.stocktitan.net/sec-filings/LNSR/def-14a-lensar-inc-definitive-proxy-statement-27959779a0ac.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:45", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LNSR) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an in-depth analysis of Lensar Inc. (NASDAQ: LNSR) with key findings and institutional trading strategies. It highlights a positive near-term sentiment that may be shifting, a broader weak alignment, and an exceptional risk-reward short setup. The analysis i", "url": "https://news.stocktradersdaily.com/news_release/150/LNSR_as_a_Liquidity_Pulse_for_Institutional_Tactics_062126034002_1782027602.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-21T03:40:00", "published_display": "21 Jun 2026 03:40", "sentiment": "negative", "sentiment_pct": 32, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "LENSAR Inc (LNSR) has an earnings forecast score of 9.00, ranking 4th in the Healthcare Equipment & Supplies industry. Analysts have a strong buy rating with an average price target of $15.00, indicating a potential upside of 37.54%. The company's expected revenue for the next qu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T06:40:51", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of LENSAR Inc (LNSR), detailing its current price momentum score of 9.17 and its trading range between a resistance level of $6.65 and a support level of $5.68. It evaluates various technical indicators like MACD, RSI, and moving average", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/technical", "source_name": "TradingKey", "published_at": "2026-06-18T06:40:51", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Institutional Confidence", "summary": "LENSAR Inc (LNSR) has an institutional shareholding score of 5.00, placing it 109th out of 204 in the Healthcare Equipment & Supplies industry. Institutional investors hold 55.41% of shares, a 10.86% increase quarter-over-quarter. Bill Nygren (OAKMX) is the largest institutional ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T06:40:51", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LENSAR Q1 earnings call highlights", "summary": "This article is a placeholder for the LENSAR Q1 earnings call highlights. No content was provided, so it is impossible to summarize or extract any financial details or company performance.", "url": "https://www.msn.com/en-us/autos/news/lensar-q1-earnings-call-highlights/ar-AA22Itty?uxmode=ruby", "source_name": "MSN", "published_at": "2026-06-11T09:09:46", "published_display": "11 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LNSR) Risk Channels and Responsive Allocation", "summary": "This article provides an AI-generated analysis for Lensar Inc. (NASDAQ: LNSR), highlighting near-term weak sentiment, a mid-channel oscillation pattern, and an exceptional 208.0:1 risk-reward setup targeting a 43.4% gain. It outlines three distinct trading strategies (Position, M", "url": "https://news.stocktradersdaily.com/news_release/1/LNSR_Risk_Channels_and_Responsive_Allocation_061026023202_1781073122.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-10T02:32:00", "published_display": "10 Jun 2026 02:32", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNSR Technical Analysis & ETF Price Forecast", "summary": "This article provides a technical analysis of LENSAR Inc (LNSR), noting a \"Strong Sell\" overall consensus based on technical indicators. While its MACD suggests neutrality, various simple moving averages (5-Day, 10-Day, 20-Day, 60-Day, 200-Day, 250-Day) indicate a \"Buy\" signal gi", "url": "https://intellectia.ai/etf/LNSR/technical", "source_name": "Intellectia AI", "published_at": "2026-06-09T18:39:05", "published_display": "09 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) CEO receives 130,662 RSUs vesting over four years", "summary": "LENSAR, Inc.'s CEO, Nicholas T. Curtis, was granted 130,662 restricted stock units (RSUs) at no purchase price. These RSUs will vest in four equal annual installments, contingent on his continued service to the company. Following this award, Curtis directly holds 1,122,758 shares", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-c9c7307b3102.html", "source_name": "Stock Titan", "published_at": "2026-06-06T09:40:19", "published_display": "06 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) COO granted 34,843 RSUs in four-year vesting award", "summary": "LENSAR's Chief Operating Officer, Alan B. Connaughton, was granted 34,843 restricted stock units (RSUs) on June 3, 2026, as part of his compensation package. These RSUs, which represent common stock and were awarded at no cash cost, will vest in four equal annual installments, co", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-68a49613d38b.html", "source_name": "Stock Titan", "published_at": "2026-06-06T04:39:42", "published_display": "06 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) grants 13,066 RSUs to principal accounting officer", "summary": "LENSAR, Inc. (LNSR) has granted 13,066 restricted stock units (RSUs) to its Principal Accounting Officer, Kendra Wong. These RSUs will vest in four equal annual installments, contingent upon her continued service to the company. Following this award, Kendra Wong directly holds 56", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-641f8796bd52.html", "source_name": "Stock Titan", "published_at": "2026-06-06T04:39:42", "published_display": "06 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar (LNSR) director receives 17,421 RSUs, reports 1.1M+ indirect shares", "summary": "LENSAR, Inc. director Todd B. Hammer was granted 17,421 restricted stock units (RSUs) as part of his annual non-employee director compensation, which will vest in full on June 3, 2027. Following this grant, Hammer directly holds 56,083 common shares, and an additional 1,100,592 c", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-2eb9cea73466.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:40:09", "published_display": "06 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings", "summary": "LENSAR, Inc. director and greater-than-10% holder Thomas B. Ellis received a grant of 17,421 restricted stock units (RSUs) as part of his annual non-employee director compensation. These RSUs, which vest fully on June 3, 2027, increase his direct holdings to 56,083 common shares,", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-b770ce3cba5b.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:40:09", "published_display": "06 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award", "summary": "LENSAR, Inc. director Gary M. Winer received an equity award of 17,421 restricted stock units (RSUs) as part of the company's non-employee director compensation program. These RSUs, which represent one share of common stock each, will vest in full on June 3, 2027, provided his co", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-c8abc1667d79.html", "source_name": "Stock Titan", "published_at": "2026-06-05T21:40:09", "published_display": "05 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3", "summary": "LENSAR, Inc.'s Interim CFO, Michael A. Rossi, has filed an initial SEC Form 3, which is a required disclosure when an executive becomes a reporting insider. This filing indicates Mr. Rossi's insider status but does not report any current transactions or beneficial holdings of com", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-3-lensar-inc-initial-statement-of-beneficial-ownership-bd453455f2e5.html", "source_name": "Stock Titan", "published_at": "2026-06-05T21:40:09", "published_display": "05 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lensar-lnsr-story-shifting-failed-201441971.html", "source_name": "Simply Wall St.", "published_at": "2026-06-04T20:14:41+00:00", "published_display": "04 Jun 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar (LNSR) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/150f6b3a-3739-3ec8-98b2-b161475f3fd4/lensar-%28lnsr%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-01T17:10:46+00:00", "published_display": "01 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar (LNSR) Q4 2025 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPbDVBMTF5VUM2Vzl1SDRJbFJKYnE5MlluQ3BQZHhNX3J6Zk9rZC1IbkNVemhOeHdIRVdUdG85elp0a2F4cXh0bmk4Qk9OU3RKazhILTM1UWJxSDdydlh6ZWZYdnZqMjRSSm5wQ1JxeHVYalRvYXp6bk93Z3VmZDZqOURRWGlLZ1NQb1BQS2lRcnV0OVYxVlNEQ0hFT2xIVGhNTVFzZ0d1VzFESHJNTUF0V2VnMmlYYnZwa2c?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Appoints Interim CFO, Accelerates Governance Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOY25GZHc0ZDBrc19qR2dmSk1oVWdGLUVJSGVaNTg0U3FtVC1SSlFSWkxjWlRjTlRwMXFCSFBmWXl6cGpXN2dWb2ZGeTBibnlkcDB4M2RNNnNjTWxNbkZXalV4cy1Oa3VfUU5mdUo3ZnZDczdGTXI5dTRiZjFmU0d0MEdrelltQm5FdHRZSFBpT1BXd1JhYVJTSHdoNV91bnV2bWQ2OEZvWFFfVExpS3FSRDRTTkItWnhEY1EwZGJTSllJUTA5R1VTN3B1cUh5a3dGN2JnZUw5RQ?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LENSAR\u00ae Reports First Quarter 2026 Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPUW9ieE9RWVVKZEcyaXd6ZmduaUZnak52WjVPS0N4SHlGTTR3dkhNWV9keUhYZ2NGNUhHSHAtU1ZfSUxraXNpd0JsN3ZwTnNGZGs1dnBsN1liaVVzTkJucUY4Ykk4cW1sSUgzOEVENzEydVkwOVdYaElLUFFtUF9oWkN6ek1TRkgyS1B1MktDdVpUeG96RWh4eXc3bE5YNVZ1MDlqVjJPX1NDOTNCQVYzQ0xkb3BzbTZYSngySWNQRm00V241c1lXeW9wbkdPTnVfR2FfbmpkWjJrQQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR\u00ae to Report First Quarter 2026 Results on May 8, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lensar-report-first-quarter-2026-110000065.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T11:00:00+00:00", "published_display": "30 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cedar Grove Capital Management\u2019s Views on LENSAR (LNSR)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cedar-grove-capital-management-views-130044940.html", "source_name": "Insider Monkey", "published_at": "2026-04-20T13:00:44+00:00", "published_display": "20 Apr 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQV1lRTG1BWHVUWTBmOTJaZ1ZqZXZzUnVXbkFMdng4TUJwcmxlMHFiM0VOc1YyQ3ZSMVMwUm5pTTN6NVAwS0NOY1dmMW93cnFZby10dXp0b0x5Zkg5dFN3SEx3Y1ZMVDgwbmxpejdrUmxkNjFvVXZFVFQzVWxBdWhtUDk3QUlJYzQzU1hlUEdPTmhVZGZrczd2Ni1FOWVUTGlT?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "U.S. Federal Trade Commission \u2013 Proposed Merger Between Alcon, Inc. And Lensar, Inc. Abandoned Following Competition Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPa01zZTBhUmlTOXl1WC1yTGZpN0FvOEZoUWZMTzRqRHFEdWtGV21jQ183Sk10UmVSSUlZZUd0VVFjeTIxeHRHUGtUTFBDSG1iT2xia3FlYkZmaERCMmliWk8xSjJ4WjlWQVBENVU1WF9paFZNWkRPYmIxZHJ2TXNCenFXRVVJa3FLWEFaUEozei04dmxOeTFhRVU2M0ZOUWtEUWU5c2RxZ0VHYl8zWDhCLXZsVnhXMDdsWkNNanQwQTNBa193RmlQV1ljMGFOU0tTU19XdDhORFU4YnBFcWRz?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOU240YVlzTDcwN3ZfMnczRk8teTBhVkdhclRzRTdvMnN5cDJHdWVXZGxRVExlTXhrdDVtNGlGRHlDNU5YaGdEYy1KUkVRblo5aFp0MmN0bFJQVWJmR2VQc3o0V0JYcXk5X3YwVkdIY3JWa1ZvUFVkYnRCbl9uVGFPd1dPTzhBOWd5TnF3UlloRHNDMlYyMUd5M0RvYlRkczA?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LENSAR\u00ae Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPaE13VHpoYkI4UUhCM0JUMEQ3Qk9ZSmRtN05PdFJ1bDRwTHhtbFJnalpsNTJRRFZmbFp5UjhjNlBmZ3BOTXQ4N0pqLTNYUHpRNVlLbEJySkNOQVlaZ2l3bVRvMmtTS2VGeFdaSGhnQjlDUE9ua2ZoMHpSZUY2Rk5KOGpBbjVFbHFJQ0N0V3psaHJNVllWc0FDc2R2Q19TRkJZTmVVWHZR?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR ($LNSR) Releases Q4 2025 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOM0pURTQ5Y2dOazRvZEIwY3N0Y3JzbG4zM0VVbjJlWl9HNE1hZjBRVnBzQm83cmZ4MlJaRlhfbmJlNmdoaTJMdC1vRURiYVd3dEJLZE5XdFRERGxQSjRuSWpKajdVbXRIcVZBMFRoMko3UndRankzQVBCc0lnUGFlRjRsckNNUzVKclY2VVE3R05iUVJvMENDWHl3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOcDFUYTBQYWM5YnVLQkgyeGhtMDRSRUxxTC12dGYxUmlZSGQ5SjNQRmI5UlpkYm45eWVUUmUwbFhxQlkyZ0U1SlZ3MEY0c1Nkek5YQ3BqQktjOWFkaWlKY29ucGNMYVZvT2ttWENIamUzX0YwYWwtLVhQSkVPWHRlSk4yRVkwdExFQW5OU3hONA?oc=5", "source_name": "TIKR.com", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQMDltNGRITVQ4bVp6S3pnS1paZFNLelRvclpEbFB5NVJmc2dwcHBlYy1TdjkyTDJFQXVDM2lGVUU0aDd2SXp5akFNQ1RvS0M2Y3JuNzN3Ymd5bnZRQ200djkyWWg0OWc3RGJFd3JHdzhDN1N3ampXNjFZZlRnT2djZDlPR25Bc3Z0Y3Y4STVrSGJfamVXVzk0a1lFNWQwNXdXSkdHUV9tb1pfUE50c2YtdQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTC opposition ends Alcon\u2013LENSAR cataract-surgery deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQcGRtSUxSRm9nOGZYM0laMU9BQTBrM2FGOElPQkN6Y2NPbjl1d1dLbE5yUVFYdkc1RjFTcTVTcnFlZDFjZWh0aVRHTnFIQzRpb3VZb1R2aUs1MllpOWh6QjhvUVhLZ3IxNnBoS1pnWHBrRHBHMHB6aFREa20wQk13ZGxSenk3THhOSVZjOWdhcVBHR3AzT2F0Sy1iREJjZzk4SEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOaHJjTkVQYzFrTElQMG9fbDl0R1c4V1h1dDg1NVd1eDhVdk42WWM4WXN4S18tV2V0VWRCUXBha3Mxd0FtY2thbmpMMDZnRDFNaFpUbGI0YmtnSjVUNDJ3Z1NoRmY3TzN2ZnhqYV85dEFxYS1nbU5fSV9tS2VySnZ3M1FiQkFGY0tqZV9XQWFnRTVOelRlQnhBejdaamE0V1dVREp5a0c5XzQyd0FsbUtaZWNOSjRpYzQ2STl3NUZuNFU4emNuWXlkRjBDRVFnaEZjb25LN1JhNU85b3hqc0tN?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eye-surgery laser maker LENSAR drops Alcon deal after FTC move to enjoin merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPRXZYUlp0bTVrM0E5a1R2VUJnclI0TnIwaGtydEtWRUo5MnBjejdPT2xCZzFFaldIai15cEpBR2NURXdPWmFYNm9LdFUtSmtFd2s4YzdFWDJJWVJBaHB5U3NNWm1Xd1Q2dFN1QjAyeEJqUWdRa2pMMDY5aF9hYmhBWnJ2MTRhQk94cUNfaTg0NEhZZDVxZmpiS3pLMTFLa0pFZDhZY2hWQzVVOFhYOUdzUWl0R09OQ0xkWEttV3JUY18?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LENSAR, Inc. Provides Update on Acquisition Status by Alcon Research, LLC", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNZlBxSHlKMUh4S09XckxEeW01aVU2T0pHUUFPWDl3NDE3MGRGZlgwUUx3QnVGQWJZSHZCYjNuQ1E4alpLWGNpLUtOZ1JqYmljckxodWVxQ0Y3dDZKYmZZQjBBWjBkaFFtQzdwMHZKd0hOVnZHWjFfUmNNSlZqMWpCLWd2SzFEdXRzWDlndW91WXdSVjhETl9NNnl1cTFscDVKWVNKTFByaFJhQnlsV1dF?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOV0VuRDVEZ3BPSi1ZN2duNklqVnNuR1Fkc1JRNXV6ODZobjIyX2VGS3JlZEp4R2tMUGNYZk1mOXc3LXdCeUhqNHVTQlpnV19EVzcySDNybjdCRUVGZEJ6bkxWSUNMTFd1ZFY3c1lXY0ZjdWduMWN0NjdQUks4RmhTNTdka19xVlM3cXZZVmZwS09yeVNmcHJ0OGM4bkxiTzVGcU5SbFY1Yi0ySHcxUGZQLTVtOTZZZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price-Driven Insight from (LNSR) for Rule-Based Strategy", "summary": "This article provides a price-driven analysis for Lensar Inc. (LNSR), highlighting near-term weak sentiment and potential long-term weakness resumption. It outlines specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, with de", "url": "https://news.stocktradersdaily.com/news_release/1/Price-Driven_Insight_from_LNSR_for_Rule-Based_Strategy_071326060001_1783936801.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-13T07:43:17", "published_display": "13 Jul 2026 07:43", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "This article displays the \"Price to earnings forward\" metric for LENSAR, Inc. (NASDAQ:LNSR) on TradingView. It presents financial information for the company, accessible through various features on the platform. The content is primarily a data point presented within the TradingVi", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T18:11:11", "published_display": "05 Jul 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "The article provides a financial snapshot for LENSAR, Inc. (NASDAQ:LNSR), specifically focusing on its \"Price to book forward\" metric. It appears to be an excerpt from a financial data platform like TradingView, indicating that the market for LNSR is currently closed with no trad", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T05:40:37", "published_display": "02 Jul 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LNSR) Price Dynamics and Execution-Aware Positioning", "summary": "This article analyzes Lensar Inc. (NASDAQ: LNSR) with a focus on its price dynamics and execution-aware positioning. It highlights weak near-term sentiment impacting the stock and identifies resistance levels, suggesting a potential short setup with significant downside. The repo", "url": "https://news.stocktradersdaily.com/news_release/149/LNSR_Price_Dynamics_and_Execution-Aware_Positioning_070226045202_1782982322.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-02T05:11:29", "published_display": "02 Jul 2026 05:11", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "This article displays financial information for LENSAR, Inc. (NASDAQ: LNSR), specifically its forward price-to-sales ratio. It indicates the market status as closed with no trades and highlights that the content is provided by TradingView, with market data from ICE Data Services ", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T00:40:05", "published_display": "02 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of LENSAR, Inc. \u2013 NASDAQ:LNSR", "summary": "This article focuses on the enterprise value to revenue forward metric for LENSAR, Inc. (NASDAQ: LNSR) on TradingView. It appears to be an unpopulated financial data page, showing the structure for displaying such information rather than actual figures. The content primarily cons", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T07:14:55", "published_display": "01 Jul 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) added to Russell Microcap Value Benchmark Index", "summary": "LENSAR, Inc. (NasdaqCM: LNSR) has been added to the Russell Microcap Value Benchmark Index, as announced on June 29, 2026. This inclusion comes despite several recent exclusions from other Russell indexes, highlighting a reclassification within the Russell family of benchmarks. T", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-added-to-russell-microcap-value-benchmark-index-ce7f5fdfd988f624", "source_name": "www.marketscreener.com", "published_at": "2026-06-30T02:40:05", "published_display": "30 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 2000 Dynamic Index", "summary": "LENSAR, Inc. (NasdaqCM:LNSR) has been dropped from several Russell indices, including the Russell 2000 Dynamic Index, Russell 3000E Index, Russell Small Cap Completeness Index, Russell 2500 Index, Russell 3000 Index, Russell 2000 Index, Russell 3000E Growth Benchmark, and Russell", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-dropped-from-russell-2000-dynamic-index-ce7f5fdfdc8df121", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:41:35", "published_display": "29 Jun 2026 21:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 3000E Index", "summary": "LENSAR, Inc. (NasdaqCM:LNSR), a commercial-stage medical device company specializing in cataract treatment systems, has been removed from the Russell 3000E Index. The company's stock currently trades at $5.830 with a recent -0.17% change. This news follows several other index reb", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-dropped-from-russell-3000e-index-ce7f5fdfda88f527", "source_name": "marketscreener.com", "published_at": "2026-06-29T13:59:00", "published_display": "29 Jun 2026 13:59", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 2500 Index", "summary": "LENSAR, Inc. (NasdaqCM: LNSR), a medical device company specializing in advanced cataract treatment systems, has been dropped from the Russell 2500 Index. This update was reported on June 29, 2026, coinciding with several other Russell index changes for the company. LENSAR's prod", "url": "https://www.marketscreener.com/news/lensar-inc-nasdaqcm-lnsr-dropped-from-russell-2500-index-ce7f5fdfd98cf025", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T10:17:00", "published_display": "29 Jun 2026 10:17", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell Small Cap Comp Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPVDFkVTNGeE05RXo4eXRxTEtlWUxUNGE5M0NMNUJWM0NVdkhSNk1BTmhrTFd4RnNaejdfYnRwOXdXMUJXZ2FVZ1JUMnBhNGZ5YkRsZ3UwaFJhU25TaU1oLVN0M09BR01IUUNGcmcxM1I1aWQzY3V4bHE3b1kwX0U5cDZveUt1aXV6RkdRdWl4UnIxc1dCU0R3ZzVmVVI4UnZ5QjVuYmRSYTdVanB4WDhZWFRoNlUtWGFJZElGcVliYmhWRnlOM1dISnZR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc.(NasdaqCM: LNSR) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPaFFoMEVSN1JhWUNsVXptRV9NTFBJNDhZYnJJZnl4cndjdzhUaXZOZ2kxMExTLVJGejNwS2hsRDUtcDRDM29PenItcjhuRVFsNDRlWVhYSmVfQmdjVlV0OFd6QjB1QWdmNVdQT1NRMDFBazRyRzZtMk9KSGI0Y05jRkxNdGd3a0hKZERRS2NtNzhyem9Da2ZiOXRWbVRfRWxpZTVSWFgwT1prTEd5WTUtQndOWkRoNTg?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc Actuals & Estimates (NASDAQ:LNSR)", "summary": "This article provides an overview of LENSAR, Inc.'s (NASDAQ: LNSR) financial actuals and estimates, along with analyst insights and key stock information. It covers current stock price, historical highs and lows, volatility, market capitalization, upcoming earnings reports, reven", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T05:11:13", "published_display": "26 Jun 2026 05:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNSR Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for LENSAR, Inc. (LNSR) stock, detailing analyst opinions, historical price performance, and key financial metrics. It includes frequently asked questions about the company's stock, market capitalization, earnings, and volatility,", "url": "https://www.tradingview.com/symbols/NASDAQ-LNSR/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:10:22", "published_display": "26 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Valuation: PE, PB & Fair Value Analysis", "summary": "LENSAR Inc (LNSR) currently holds a valuation score of 9.27, placing it 26th out of 204 companies in the Healthcare Equipment & Supplies industry. Its P/E ratio stands at 2.34, which is 9.44% below its recent high and significantly above its recent low. However, relevant data for", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T23:39:47", "published_display": "23 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[ARS] LENSAR, Inc. SEC Filing", "summary": "This article announces an SEC filing of Form ARS by LENSAR, Inc. (LNSR) on June 23, 2026, accessible as a PDF document. The filing has a low impact and neutral sentiment according to StockTitan's Rhea-AI. The article also provides recent news and other SEC filings related to LENS", "url": "https://www.stocktitan.net/sec-filings/LNSR/ars-lensar-inc-sec-filing-e0c909ca4897.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:45", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (NASDAQ: LNSR) schedules 2026 virtual meeting, say-on-pay and auditor vote", "summary": "LENSAR (NASDAQ: LNSR) has scheduled its 2026 virtual annual shareholder meeting for August 4, 2026, at 11:00 a.m. Eastern Time. Shareholders will vote on the election of three Class III directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor for 2026,", "url": "https://www.stocktitan.net/sec-filings/LNSR/def-14a-lensar-inc-definitive-proxy-statement-27959779a0ac.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:45", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LNSR) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an in-depth analysis of Lensar Inc. (NASDAQ: LNSR) with key findings and institutional trading strategies. It highlights a positive near-term sentiment that may be shifting, a broader weak alignment, and an exceptional risk-reward short setup. The analysis i", "url": "https://news.stocktradersdaily.com/news_release/150/LNSR_as_a_Liquidity_Pulse_for_Institutional_Tactics_062126034002_1782027602.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-21T03:40:00", "published_display": "21 Jun 2026 03:40", "sentiment": "negative", "sentiment_pct": 32, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "LENSAR Inc (LNSR) has an earnings forecast score of 9.00, ranking 4th in the Healthcare Equipment & Supplies industry. Analysts have a strong buy rating with an average price target of $15.00, indicating a potential upside of 37.54%. The company's expected revenue for the next qu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T06:40:51", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of LENSAR Inc (LNSR), detailing its current price momentum score of 9.17 and its trading range between a resistance level of $6.65 and a support level of $5.68. It evaluates various technical indicators like MACD, RSI, and moving average", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/technical", "source_name": "TradingKey", "published_at": "2026-06-18T06:40:51", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Inc (LNSR) Institutional Confidence", "summary": "LENSAR Inc (LNSR) has an institutional shareholding score of 5.00, placing it 109th out of 204 in the Healthcare Equipment & Supplies industry. Institutional investors hold 55.41% of shares, a 10.86% increase quarter-over-quarter. Bill Nygren (OAKMX) is the largest institutional ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnsr/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T06:40:51", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Q1 earnings call highlights", "summary": "This article is a placeholder for the LENSAR Q1 earnings call highlights. No content was provided, so it is impossible to summarize or extract any financial details or company performance.", "url": "https://www.msn.com/en-us/autos/news/lensar-q1-earnings-call-highlights/ar-AA22Itty?uxmode=ruby", "source_name": "MSN", "published_at": "2026-06-11T09:09:46", "published_display": "11 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LNSR) Risk Channels and Responsive Allocation", "summary": "This article provides an AI-generated analysis for Lensar Inc. (NASDAQ: LNSR), highlighting near-term weak sentiment, a mid-channel oscillation pattern, and an exceptional 208.0:1 risk-reward setup targeting a 43.4% gain. It outlines three distinct trading strategies (Position, M", "url": "https://news.stocktradersdaily.com/news_release/1/LNSR_Risk_Channels_and_Responsive_Allocation_061026023202_1781073122.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-10T02:32:00", "published_display": "10 Jun 2026 02:32", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNSR Technical Analysis & ETF Price Forecast", "summary": "This article provides a technical analysis of LENSAR Inc (LNSR), noting a \"Strong Sell\" overall consensus based on technical indicators. While its MACD suggests neutrality, various simple moving averages (5-Day, 10-Day, 20-Day, 60-Day, 200-Day, 250-Day) indicate a \"Buy\" signal gi", "url": "https://intellectia.ai/etf/LNSR/technical", "source_name": "Intellectia AI", "published_at": "2026-06-09T18:39:05", "published_display": "09 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) CEO receives 130,662 RSUs vesting over four years", "summary": "LENSAR, Inc.'s CEO, Nicholas T. Curtis, was granted 130,662 restricted stock units (RSUs) at no purchase price. These RSUs will vest in four equal annual installments, contingent on his continued service to the company. Following this award, Curtis directly holds 1,122,758 shares", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-c9c7307b3102.html", "source_name": "Stock Titan", "published_at": "2026-06-06T09:40:19", "published_display": "06 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) COO granted 34,843 RSUs in four-year vesting award", "summary": "LENSAR's Chief Operating Officer, Alan B. Connaughton, was granted 34,843 restricted stock units (RSUs) on June 3, 2026, as part of his compensation package. These RSUs, which represent common stock and were awarded at no cash cost, will vest in four equal annual installments, co", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-68a49613d38b.html", "source_name": "Stock Titan", "published_at": "2026-06-06T04:39:42", "published_display": "06 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) grants 13,066 RSUs to principal accounting officer", "summary": "LENSAR, Inc. (LNSR) has granted 13,066 restricted stock units (RSUs) to its Principal Accounting Officer, Kendra Wong. These RSUs will vest in four equal annual installments, contingent upon her continued service to the company. Following this award, Kendra Wong directly holds 56", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-641f8796bd52.html", "source_name": "Stock Titan", "published_at": "2026-06-06T04:39:42", "published_display": "06 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar (LNSR) director receives 17,421 RSUs, reports 1.1M+ indirect shares", "summary": "LENSAR, Inc. director Todd B. Hammer was granted 17,421 restricted stock units (RSUs) as part of his annual non-employee director compensation, which will vest in full on June 3, 2027. Following this grant, Hammer directly holds 56,083 common shares, and an additional 1,100,592 c", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-2eb9cea73466.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:40:09", "published_display": "06 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings", "summary": "LENSAR, Inc. director and greater-than-10% holder Thomas B. Ellis received a grant of 17,421 restricted stock units (RSUs) as part of his annual non-employee director compensation. These RSUs, which vest fully on June 3, 2027, increase his direct holdings to 56,083 common shares,", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-b770ce3cba5b.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:40:09", "published_display": "06 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award", "summary": "LENSAR, Inc. director Gary M. Winer received an equity award of 17,421 restricted stock units (RSUs) as part of the company's non-employee director compensation program. These RSUs, which represent one share of common stock each, will vest in full on June 3, 2027, provided his co", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-4-lensar-inc-insider-trading-activity-c8abc1667d79.html", "source_name": "Stock Titan", "published_at": "2026-06-05T21:40:09", "published_display": "05 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3", "summary": "LENSAR, Inc.'s Interim CFO, Michael A. Rossi, has filed an initial SEC Form 3, which is a required disclosure when an executive becomes a reporting insider. This filing indicates Mr. Rossi's insider status but does not report any current transactions or beneficial holdings of com", "url": "https://www.stocktitan.net/sec-filings/LNSR/form-3-lensar-inc-initial-statement-of-beneficial-ownership-bd453455f2e5.html", "source_name": "Stock Titan", "published_at": "2026-06-05T21:40:09", "published_display": "05 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lensar-lnsr-story-shifting-failed-201441971.html", "source_name": "Simply Wall St.", "published_at": "2026-06-04T20:14:41+00:00", "published_display": "04 Jun 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar (LNSR) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/150f6b3a-3739-3ec8-98b2-b161475f3fd4/lensar-%28lnsr%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-01T17:10:46+00:00", "published_display": "01 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar (LNSR) Q4 2025 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPbDVBMTF5VUM2Vzl1SDRJbFJKYnE5MlluQ3BQZHhNX3J6Zk9rZC1IbkNVemhOeHdIRVdUdG85elp0a2F4cXh0bmk4Qk9OU3RKazhILTM1UWJxSDdydlh6ZWZYdnZqMjRSSm5wQ1JxeHVYalRvYXp6bk93Z3VmZDZqOURRWGlLZ1NQb1BQS2lRcnV0OVYxVlNEQ0hFT2xIVGhNTVFzZ0d1VzFESHJNTUF0V2VnMmlYYnZwa2c?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR Appoints Interim CFO, Accelerates Governance Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOY25GZHc0ZDBrc19qR2dmSk1oVWdGLUVJSGVaNTg0U3FtVC1SSlFSWkxjWlRjTlRwMXFCSFBmWXl6cGpXN2dWb2ZGeTBibnlkcDB4M2RNNnNjTWxNbkZXalV4cy1Oa3VfUU5mdUo3ZnZDczdGTXI5dTRiZjFmU0d0MEdrelltQm5FdHRZSFBpT1BXd1JhYVJTSHdoNV91bnV2bWQ2OEZvWFFfVExpS3FSRDRTTkItWnhEY1EwZGJTSllJUTA5R1VTN3B1cUh5a3dGN2JnZUw5RQ?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR\u00ae Reports First Quarter 2026 Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPUW9ieE9RWVVKZEcyaXd6ZmduaUZnak52WjVPS0N4SHlGTTR3dkhNWV9keUhYZ2NGNUhHSHAtU1ZfSUxraXNpd0JsN3ZwTnNGZGs1dnBsN1liaVVzTkJucUY4Ykk4cW1sSUgzOEVENzEydVkwOVdYaElLUFFtUF9oWkN6ek1TRkgyS1B1MktDdVpUeG96RWh4eXc3bE5YNVZ1MDlqVjJPX1NDOTNCQVYzQ0xkb3BzbTZYSngySWNQRm00V241c1lXeW9wbkdPTnVfR2FfbmpkWjJrQQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR\u00ae to Report First Quarter 2026 Results on May 8, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lensar-report-first-quarter-2026-110000065.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T11:00:00+00:00", "published_display": "30 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cedar Grove Capital Management\u2019s Views on LENSAR (LNSR)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cedar-grove-capital-management-views-130044940.html", "source_name": "Insider Monkey", "published_at": "2026-04-20T13:00:44+00:00", "published_display": "20 Apr 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQV1lRTG1BWHVUWTBmOTJaZ1ZqZXZzUnVXbkFMdng4TUJwcmxlMHFiM0VOc1YyQ3ZSMVMwUm5pTTN6NVAwS0NOY1dmMW93cnFZby10dXp0b0x5Zkg5dFN3SEx3Y1ZMVDgwbmxpejdrUmxkNjFvVXZFVFQzVWxBdWhtUDk3QUlJYzQzU1hlUEdPTmhVZGZrczd2Ni1FOWVUTGlT?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "U.S. Federal Trade Commission \u2013 Proposed Merger Between Alcon, Inc. And Lensar, Inc. Abandoned Following Competition Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPa01zZTBhUmlTOXl1WC1yTGZpN0FvOEZoUWZMTzRqRHFEdWtGV21jQ183Sk10UmVSSUlZZUd0VVFjeTIxeHRHUGtUTFBDSG1iT2xia3FlYkZmaERCMmliWk8xSjJ4WjlWQVBENVU1WF9paFZNWkRPYmIxZHJ2TXNCenFXRVVJa3FLWEFaUEozei04dmxOeTFhRVU2M0ZOUWtEUWU5c2RxZ0VHYl8zWDhCLXZsVnhXMDdsWkNNanQwQTNBa193RmlQV1ljMGFOU0tTU19XdDhORFU4YnBFcWRz?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOU240YVlzTDcwN3ZfMnczRk8teTBhVkdhclRzRTdvMnN5cDJHdWVXZGxRVExlTXhrdDVtNGlGRHlDNU5YaGdEYy1KUkVRblo5aFp0MmN0bFJQVWJmR2VQc3o0V0JYcXk5X3YwVkdIY3JWa1ZvUFVkYnRCbl9uVGFPd1dPTzhBOWd5TnF3UlloRHNDMlYyMUd5M0RvYlRkczA?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR\u00ae Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPaE13VHpoYkI4UUhCM0JUMEQ3Qk9ZSmRtN05PdFJ1bDRwTHhtbFJnalpsNTJRRFZmbFp5UjhjNlBmZ3BOTXQ4N0pqLTNYUHpRNVlLbEJySkNOQVlaZ2l3bVRvMmtTS2VGeFdaSGhnQjlDUE9ua2ZoMHpSZUY2Rk5KOGpBbjVFbHFJQ0N0V3psaHJNVllWc0FDc2R2Q19TRkJZTmVVWHZR?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR ($LNSR) Releases Q4 2025 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOM0pURTQ5Y2dOazRvZEIwY3N0Y3JzbG4zM0VVbjJlWl9HNE1hZjBRVnBzQm83cmZ4MlJaRlhfbmJlNmdoaTJMdC1vRURiYVd3dEJLZE5XdFRERGxQSjRuSWpKajdVbXRIcVZBMFRoMko3UndRankzQVBCc0lnUGFlRjRsckNNUzVKclY2VVE3R05iUVJvMENDWHl3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOcDFUYTBQYWM5YnVLQkgyeGhtMDRSRUxxTC12dGYxUmlZSGQ5SjNQRmI5UlpkYm45eWVUUmUwbFhxQlkyZ0U1SlZ3MEY0c1Nkek5YQ3BqQktjOWFkaWlKY29ucGNMYVZvT2ttWENIamUzX0YwYWwtLVhQSkVPWHRlSk4yRVkwdExFQW5OU3hONA?oc=5", "source_name": "TIKR.com", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQMDltNGRITVQ4bVp6S3pnS1paZFNLelRvclpEbFB5NVJmc2dwcHBlYy1TdjkyTDJFQXVDM2lGVUU0aDd2SXp5akFNQ1RvS0M2Y3JuNzN3Ymd5bnZRQ200djkyWWg0OWc3RGJFd3JHdzhDN1N3ampXNjFZZlRnT2djZDlPR25Bc3Z0Y3Y4STVrSGJfamVXVzk0a1lFNWQwNXdXSkdHUV9tb1pfUE50c2YtdQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTC opposition ends Alcon\u2013LENSAR cataract-surgery deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQcGRtSUxSRm9nOGZYM0laMU9BQTBrM2FGOElPQkN6Y2NPbjl1d1dLbE5yUVFYdkc1RjFTcTVTcnFlZDFjZWh0aVRHTnFIQzRpb3VZb1R2aUs1MllpOWh6QjhvUVhLZ3IxNnBoS1pnWHBrRHBHMHB6aFREa20wQk13ZGxSenk3THhOSVZjOWdhcVBHR3AzT2F0Sy1iREJjZzk4SEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOaHJjTkVQYzFrTElQMG9fbDl0R1c4V1h1dDg1NVd1eDhVdk42WWM4WXN4S18tV2V0VWRCUXBha3Mxd0FtY2thbmpMMDZnRDFNaFpUbGI0YmtnSjVUNDJ3Z1NoRmY3TzN2ZnhqYV85dEFxYS1nbU5fSV9tS2VySnZ3M1FiQkFGY0tqZV9XQWFnRTVOelRlQnhBejdaamE0V1dVREp5a0c5XzQyd0FsbUtaZWNOSjRpYzQ2STl3NUZuNFU4emNuWXlkRjBDRVFnaEZjb25LN1JhNU85b3hqc0tN?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eye-surgery laser maker LENSAR drops Alcon deal after FTC move to enjoin merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPRXZYUlp0bTVrM0E5a1R2VUJnclI0TnIwaGtydEtWRUo5MnBjejdPT2xCZzFFaldIai15cEpBR2NURXdPWmFYNm9LdFUtSmtFd2s4YzdFWDJJWVJBaHB5U3NNWm1Xd1Q2dFN1QjAyeEJqUWdRa2pMMDY5aF9hYmhBWnJ2MTRhQk94cUNfaTg0NEhZZDVxZmpiS3pLMTFLa0pFZDhZY2hWQzVVOFhYOUdzUWl0R09OQ0xkWEttV3JUY18?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENSAR, Inc. Provides Update on Acquisition Status by Alcon Research, LLC", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNZlBxSHlKMUh4S09XckxEeW01aVU2T0pHUUFPWDl3NDE3MGRGZlgwUUx3QnVGQWJZSHZCYjNuQ1E4alpLWGNpLUtOZ1JqYmljckxodWVxQ0Y3dDZKYmZZQjBBWjBkaFFtQzdwMHZKd0hOVnZHWjFfUmNNSlZqMWpCLWd2SzFEdXRzWDlndW91WXdSVjhETl9NNnl1cTFscDVKWVNKTFByaFJhQnlsV1dF?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOV0VuRDVEZ3BPSi1ZN2duNklqVnNuR1Fkc1JRNXV6ODZobjIyX2VGS3JlZEp4R2tMUGNYZk1mOXc3LXdCeUhqNHVTQlpnV19EVzcySDNybjdCRUVGZEJ6bkxWSUNMTFd1ZFY3c1lXY0ZjdWduMWN0NjdQUks4RmhTNTdka19xVlM3cXZZVmZwS09yeVNmcHJ0OGM4bkxiTzVGcU5SbFY1Yi0ySHcxUGZQLTVtOTZZZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 94, "total_relevant": 61, "sentiment_summary": {"positive": 8, "negative": 8, "neutral": 45, "score": 50, "total": 61, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 13.2, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 10.17, "count": 21}, {"event": "deals", "label": "Deals and strategy", "weight": 5.1, "count": 8}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 8, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 6.01, "latest_week": "2026-07-10", "one_week_move": -6.1, "four_week_move": 3.3, "twelve_week_move": 1.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.441109, "market_dynamics_buy_signal": false, "relative_strength": -48.943693, "fair_value_gap": -20.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.1827, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.1% over one week, +3.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 56, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 11}, {"label": "Stock Titan", "count": 11}, {"label": "TradingView", "count": 6}, {"label": "Stock Traders Daily", "count": 4}, {"label": "marketscreener.com", "count": 4}, {"label": "TradingKey", "count": 4}, {"label": "www.marketscreener.com", "count": 3}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 51}, {"label": "Industry context", "count": 10}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 21}, {"label": "Deals and strategy", "count": 8}, {"label": "Analyst action", "count": 4}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "51", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.1% over one week, +3.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Price-Driven Insight from (LNSR) for Rule-Based Strategy"}], "updated_at": "2026-07-18T05:52:39.593530+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}